James Lovgren
About James Lovgren
James Lovgren serves as the Senior Vice President of Global Marketing at MaxCyte, Inc. He has extensive experience in the life sciences sector, having held various leadership roles at notable companies and a strong educational background in business and biology.
Work at MaxCyte, Inc.
James Lovgren serves as the Senior Vice President of Global Marketing at MaxCyte, Inc. since 2021. In this role, he is responsible for overseeing the company's marketing strategies and initiatives, focusing on advancing the company's position in the cell therapy and gene therapy markets. His leadership contributes to MaxCyte's efforts in providing innovative solutions for drug development and personalized medicine.
Current Role as Venture Advisor at MBX Capital
Since 2020, James Lovgren has been working as a Venture Advisor at MBX Capital. In this remote position, he provides strategic guidance and insights to the firm, leveraging his extensive experience in the life sciences sector. His role involves identifying investment opportunities and advising on market trends that impact biotechnology and healthcare investments.
Previous Experience at Thermo Fisher Scientific
James Lovgren held multiple roles at Thermo Fisher Scientific between 2018 and 2020. He served as the Director of Global Product Management for one year in Lancaster, United Kingdom, followed by a position as Senior Director & General Manager for Cell and Gene Therapy in the Greater San Diego Area. His work focused on product development and management in the rapidly evolving field of cell and gene therapy.
Educational Background and Certifications
James Lovgren has a diverse educational background. He earned a Bachelor of Science in Biology from the University of North Florida. He also holds an MBA from North Carolina State University, focusing on management. Additionally, he completed an Executive Strategy Program at Saïd Business School, University of Oxford, and has pursued various executive education programs at institutions such as the University of Pennsylvania and the University of North Carolina at Chapel Hill.
Expertise in Life Sciences and Business Development
James Lovgren possesses a strong expertise in cell therapy, stem cell research, genomics, and personalized medicine. He has a proven track record in managing global product portfolios exceeding $250 million in value. His experience spans startups, growth-stage companies, and Fortune 150 biotechnology firms, where he has demonstrated strategic thinking and leadership in driving revenue growth and market expansion.